Anthera Pharmaceuticals, Inc. (ANTH)
OTCMKTS: ANTH · Delayed Price · USD
0.0001
0.00 (0.00%)
Aug 29, 2024, 4:00 PM EDT - Market closed
Anthera Pharmaceuticals Market Cap
Anthera Pharmaceuticals has a market cap or net worth of $26.18 as of August 30, 2024. Its market cap has decreased by -100.00% in one year.
Market Cap
26.18
Enterprise Value
n/a
1-Year Change
-100.00%
Ranking
n/a
Category
Stock Price
$0.00
Market Cap Chart
Since March 1, 2010, Anthera Pharmaceuticals's market cap has decreased from $121.30M to $26.18, a decrease of -100.00%. That is a compound annual growth rate of -84.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2018 | 3.10M | -86.46% |
| Dec 29, 2017 | 22.90M | -15.81% |
| Dec 30, 2016 | 27.20M | -85.30% |
| Dec 31, 2015 | 185.00M | 411.05% |
| Dec 31, 2014 | 36.20M | -38.95% |
| Dec 31, 2013 | 59.30M | 21.02% |
| Dec 31, 2012 | 49.00M | -80.49% |
| Dec 30, 2011 | 251.20M | 56.80% |
| Dec 31, 2010 | 160.20M | 32.07% |
| Mar 1, 2010 | 121.30M | - |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 846.58B |
| Novo Nordisk | 607.12B |
| UnitedHealth Group | 546.27B |
| Johnson & Johnson | 395.34B |
| AbbVie | 344.86B |
| Merck & Co. | 297.74B |
| AstraZeneca | 270.84B |
| Novartis AG | 243.30B |